Yuanlin Wu
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 9
- MicroRNA in disease regulation 3
-
- Immune Cell Function and Interaction 3
-
- Cancer Immunotherapy and Biomarkers 3
- CAR-T cell therapy research 2
-
- RNA modifications and cancer 8
-
- Ferroptosis and cancer prognosis 4
- Lung Cancer Treatments and Mutations 3
- Cited by
- Cancer ResearchImmunologyOncology
In The Last Decade
Yuanlin Wu
24 papers receiving 464 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 181
- Immunology 97
- Oncology 118
- Molecular Biology 281
- Pulmonary and Respiratory Medicine 77
Countries citing papers authored by Yuanlin Wu
This map shows the geographic impact of Yuanlin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanlin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanlin Wu more than expected).
Fields of papers citing papers by Yuanlin Wu
This network shows the impact of papers produced by Yuanlin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanlin Wu. The network helps show where Yuanlin Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yuanlin Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 6 | |
| 6 | 2022 | 35 | |
| 7 | 2022 | 26 | |
| 8 | 2022 | 7 | |
| 9 | 2022 | 7 | |
| 10 | 2021 | 23 | |
| 11 | 2020 | 25 | |
| 12 | 2020 | 25 | |
| 13 | 2020 | 21 | |
| 14 | 2020 | 11 | |
| 15 | 2020 | 9 | |
| 16 | 2020 | 35 | |
| 17 | 2019 | 23 | |
| 18 | 2019 | 121 | |
| 19 | 2018 | 49 | |
| 20 | 2014 | 9 |
About Yuanlin Wu
Yuanlin Wu is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 24 papers that have together received 469 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (8 papers), Ferroptosis and cancer prognosis (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immune Cell Function and Interaction (3 papers), MicroRNA in disease regulation (3 papers), Lung Cancer Treatments and Mutations (3 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Cancer Research (181 citations), Immunology (97 citations) and Oncology (118 citations). Yuanlin Wu has collaborated with scholars based in China and Hong Kong. Frequent co-authors include Xu Wu, Jing Shen, Yueshui Zhao, Mingxing Li, Zhangang Xiao, Jianhua Yin, Chi Hin Cho, Lingling Zhang, Parham Jabbarzadeh Kaboli and Qijie Zhao.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.